Introduction to Growth Hormone Secretagogues
Growth hormone secretagogues (GHS) represent a class of compounds that stimulate the body's natural growth hormone (GH) production rather than providing exogenous GH directly. This approach has significant research interest because it may better preserve natural regulatory mechanisms while still augmenting GH levels.
This comprehensive overview examines the major classes of secretagogues, their mechanisms, and research applications.
Growth Hormone Physiology
Understanding Natural GH Release
GH is released from the anterior pituitary in a pulsatile pattern regulated by:
Stimulating Factors:
- GHRH (Growth Hormone Releasing Hormone) from hypothalamus
- Ghrelin from stomach
- Sleep (GH peaks during slow-wave sleep)
- Exercise
- Fasting
- Low blood glucose
Inhibiting Factors:
- Somatostatin from hypothalamus
- IGF-1 (negative feedback)
- High blood glucose
- Free fatty acids
- Age (progressive decline)
The Somatopause
GH secretion declines with age:
- Peaks in adolescence
- Decreases ~14% per decade after age 30
- By age 60, levels may be 20-30% of young adult
- Contributes to age-related body composition changes
This decline drives interest in secretagogues for aging research.
Classes of GH Secretagogues
GHRH Analogs
Mechanism:
- Bind to GHRH receptors on pituitary somatotrophs
- Stimulate GH synthesis and release
- Require somatostatin to be low for maximal effect
Key Compounds:
Sermorelin:
- GHRH(1-29) - first 29 amino acids of GHRH
- Short half-life (~10-20 minutes)
- Requires frequent administration
- Previously FDA-approved (discontinued)
CJC-1295 (no DAC / Mod GRF 1-29):
- Modified GHRH(1-29)
- Increased stability
- Half-life ~30 minutes
- Common research compound
CJC-1295 with DAC:
- Drug Affinity Complex enables albumin binding
- Extended half-life (~8 days)
- Less pulsatile release pattern
- Once or twice weekly administration
Tesamorelin:
- GHRH analog with N-terminal modification
- FDA-approved for HIV-lipodystrophy
- Best-studied GHRH analog
- Limited availability for general research
Growth Hormone Releasing Peptides (GHRPs)
Mechanism:
- Bind to ghrelin receptor (GHS-R1a)
- Amplify GH pulse amplitude
- Suppress somatostatin
- Synergize with GHRH
Key Compounds:
GHRP-6:
- First widely used GHRP
- Strong GH release
- Significant appetite stimulation (ghrelin effect)
- May increase cortisol and prolactin
- See our GHRP-2 vs GHRP-6 comparison
- Strong GH release
- Less appetite stimulation than GHRP-6
- Some cortisol and prolactin elevation
- Popular research compound
- Most selective GHRP
- Minimal cortisol or prolactin increase
- Minimal appetite stimulation
- "Cleanest" GH release
- Very popular in research
Hexarelin:
- Potent GH release
- May cause more desensitization
- Limited availability
- Less commonly used
Comparison Table
| Compound | GH Release | Appetite | Cortisol | Prolactin | Selectivity |
|---|---|---|---|---|---|
| GHRP-6 | Strong | High | Moderate | Moderate | Low |
| GHRP-2 | Strong | Moderate | Low-Mod | Low-Mod | Moderate |
| Ipamorelin | Moderate | Minimal | Minimal | Minimal | High |
| Hexarelin | Very Strong | Moderate | Moderate | Moderate | Low |
Synergy: Combining GHRH + GHRP
The Rationale
Combining GHRH analogs with GHRPs produces synergistic effects:
Why It Works:
- GHRP suppresses somatostatin
- Creates optimal window for GHRH action
- GHRH stimulates GH synthesis and release
- GHRP amplifies pulse amplitude
- Combined effect exceeds sum of individual effects
Common Combinations
- Most popular combination
- GHRH + selective GHRP
- Minimal side effects
- Well-researched synergy
CJC-1295 + GHRP-2:
- Stronger GH release
- More side effects
- Used when maximal stimulation desired
Research Evidence
Studies demonstrate:
- Combined administration produces greater GH release
- Synergy is more than additive
- Effect is consistent across protocols
- May better mimic physiological patterns
Research Applications
Body Composition
GH Effects on Composition:
- Lipolysis (fat breakdown)
- Protein synthesis support
- Lean mass effects
- Regional fat distribution
Secretagogue Research:
- Studies on fat reduction
- Lean mass preservation
- Metabolic effects
- Comparison with direct GH
Sleep and Recovery
GH and Sleep:
- Natural GH peaks during slow-wave sleep
- Secretagogues may enhance this
Research Areas:
- Sleep quality improvements
- Recovery optimization
- Training adaptations
- Overtraining prevention
Anti-Aging
Addressing Somatopause:
- Restoring youthful GH levels
- Body composition normalization
- Skin and connective tissue
- Cognitive effects
See our anti-aging guide for 50+.
Clinical Applications
Established Uses:
- Growth hormone deficiency diagnosis
- Tesamorelin for HIV-lipodystrophy
- Research in various conditions
Investigational:
- Obesity and metabolic syndrome
- Sarcopenia (muscle loss with aging)
- Frailty in elderly
- Wound healing
Administration Considerations
Timing
Optimal Timing:
- Fasted state (2-3 hours after eating)
- Before bed (aligns with natural peak)
- Pre-exercise (some protocols)
- 30-60 minutes before eating
Why Fasting Matters:
- Glucose and fatty acids suppress GH release
- Fasting optimizes response
- Carbohydrates particularly blunting
See our timing and dosing guide.
Frequency
Short Half-Life Compounds (most):
- 2-3 times daily
- Common: morning, pre-workout, pre-bed
- Consistency important
CJC-1295 with DAC:
- 1-2 times weekly
- Sustained elevation rather than pulses
- Different physiological pattern
Reconstitution and Storage
All secretagogues require:
- Proper reconstitution with bacteriostatic water
- Refrigerated storage after reconstitution
- Protection from light
- Sterile technique
See our reconstitution guide and storage guide.
Side Effects and Considerations
Common Effects
Generally Mild:
- Water retention (early)
- Tingling/numbness (sign of elevated GH)
- Injection site reactions
- Head rush (transient, with some compounds)
Compound-Specific
GHRP-6:
- Intense hunger (can be significant)
- Cortisol elevation
GHRP-2:
- Moderate hunger increase
- Some cortisol effect
Ipamorelin:
- Minimal side effects
- Most well-tolerated
Longer-Term Considerations
Pituitary Concerns:
- Desensitization possible (especially Hexarelin)
- Cycling may be prudent
- Less concern than with direct GH
IGF-1 Elevation:
- GH increases IGF-1
- Theoretical concerns about cell proliferation
- Monitor with blood tests
- Context-dependent risk assessment
Quality and Sourcing
Importance
As research compounds, quality varies:
- Purity affects response
- Contamination risks
- Proper identification essential
Verification
- Third-party testing certificates
- Mass spectrometry verification
- HPLC purity data
- See supplier guide
Conclusion
Growth hormone secretagogues offer research tools for studying GH physiology and its effects on various biological processes. The combination of GHRH analogs (like CJC-1295) with selective GHRPs (like Ipamorelin) provides a synergistic approach that may better preserve natural regulatory mechanisms than direct GH administration.
Key principles:
- Two pathways - GHRH and ghrelin receptor
- Synergy - combinations more effective than singles
- Selectivity - Ipamorelin minimizes side effects
- Timing - fasted administration optimizes response
- Quality - essential for meaningful research
Understanding these compounds provides a foundation for research into aging, body composition, recovery, and various clinical applications.
Related Resources: